Premium
EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL
Author(s) -
Ghia P.,
Flinn I.W.,
Laman.,
Montillo M.,
Illés Á.,
Etienne G.,
Delgado J.,
Kuss B.J.,
Tam C.S.,
Offner F.,
Bosch F.,
Davids M.S.,
Jäger U.,
Cymbalista F.,
Weaver D.T.,
Lustgarten S.,
Youssoufian H.,
Stilgenbauer S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.30_2630
Subject(s) - medicine , neutropenia , diarrhea , rash , adverse effect , gastroenterology , mucositis , febrile neutropenia , refractory (planetary science) , surgery , toxicity , physics , astrobiology